Insights

Recent Acquisition Epizyme was acquired by Clementiapharma, indicating potential synergies and expanded product offerings. This presents an opportunity for cross-selling and leveraging the combined expertise of both companies in the biotechnology sector.

Financial Update Despite recent legal issues and investigations, Epizyme's initial public offering and financing history showcase strong investor interest. Sales development representatives can leverage this positive financial track record to build trust and credibility with potential investors or partners.

Key Partnerships Epizyme's partnership with Roche opens avenues for collaboration with a prominent player in the pharmaceutical industry. Leveraging this partnership can lead to potential sales opportunities by tapping into Roche's network and resources.

Talented Leadership With the appointment of Jerald Korn as Chief Operating Officer, Epizyme strengthens its leadership team. Sales professionals can leverage the credibility and expertise of the leadership team to forge strategic partnerships and drive sales growth.

Innovative Research Focus Epizyme's dedication to developing novel epigenetic therapies demonstrates a commitment to cutting-edge research. Sales development representatives can leverage this innovative focus to position Epizyme as a leader in advancing cancer treatments, appealing to healthcare providers and investors seeking groundbreaking solutions.

Similar companies to Epizyme

Epizyme Tech Stack

Epizyme uses 8 technology products and services including Hyperion, Oracle, IQVIA, and more. Explore Epizyme's tech stack below.

Hyperion
Corporate Performance Management
Oracle
Enterprise
IQVIA
Health Platform
Google
Miscellaneous
Office 365
Office Suites
Boomi
Platform As A Service
Yoast SEO
Search Engines
Nginx
Web Servers

Media & News

Epizyme's Email Address Formats

Epizyme uses at least 1 format(s):

Epizyme Email Formats	Example	Percentage
FLast@epizyme.com	JDoe@epizyme.com	89%
Last@epizyme.com	Doe@epizyme.com	9%
FL@epizyme.com	JD@epizyme.com	1%
First_Last@epizyme.com	John_Doe@epizyme.com	1%

Frequently Asked Questions

Where is Epizyme's headquarters located?

Epizyme's main headquarters is located at 400 Technology Square 4th floor Cambridge, MA 02139 US. The company has employees across 2 continents, including North AmericaEurope.

What is Epizyme's phone number?

You can contact Epizyme's main corporate office by phone at

+1-617-229-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Epizyme's stock symbol?

Epizyme is a publicly traded company; the company's stock symbol is EPZM.

What is Epizyme's official website and social media links?

Epizyme's official website is epizyme.com and has social profiles on LinkedIn.

What is Epizyme's SIC code NAICS code?

Epizyme's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 446110 - Pharmacies and Drug Stores.

How many employees does Epizyme have currently?

As of March 2022, Epizyme has approximately 246 employees across 2 continents, including North AmericaEurope. Key team members include Chief Strategy And Business Officer: M. R.Chief Of Staff, Clinical Development: A. J. B.Vice President Finance: D. M.. Explore Epizyme's employee directory with LeadIQ.

What industry does Epizyme belong to?

Epizyme operates in the Biotechnology Research industry.

What technology does Epizyme use?

Epizyme's tech stack includes HyperionOracleIQVIAGoogleOffice 365BoomiYoast SEONginx.

What is Epizyme's email format?

Epizyme's email format typically follows the pattern of . Find more Epizyme email formats with LeadIQ.

When was Epizyme founded?

Epizyme was founded in 2007.

Epizyme

Biotechnology ResearchMassachusetts, United States201-500 Employees

Epizyme is dedicated to rewriting treatment for people with cancer through targeted epigenetic medicines. We aspire to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action directed at specific causes of hematological malignancies and solid tumors. 
 
Our research is yielding exciting new targets for which we are developing novel small molecule programs with the goal of expanding on a pipeline of clinical candidates. Our exceptional team is dedicated to bringing epigenetic therapies to the many patients who need them. Learn more at www.epizyme.com.
 
For our community guidelines, visit https://epzy.me/communityguidelines.

Company Overview

Headquarters: 400 Technology Square 4th floor Cambridge, MA 02139 US
Phone number: ✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-617-229-****
Website: epizyme.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: EPZM
NAICS Code: 446110 - Pharmacies and Drug Stores
Founded: 2007
Employees: 201-500

Media & News

Funding & Financials

Company Leadership

M. R.
Chief Strategy And Business Officer
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. J. B.
Chief Of Staff, Clinical Development
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. M.
Vice President Finance
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Z. Z.
Executive Director And Chief Ip Counsel
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. G.
Senior Vice President Medical (hematology & Solid Tumors)
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

J. C.
Vice President, Program & Portfolio Management
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. S. P. D.
Vp, Head Of Nonclinical Development
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. M.
Senior Vice President Head Of Commercial
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Director Of People Operations
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. W.
Executive Director, Clinical Research
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Epizyme and Millions of Other Companies
Sign up for full access to Epizyme information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Epizyme

Schrödinger

Peloton Therapeutics

Cullinan Therapeutics

Revolution Medicines

Repare Therapeutics

Syros Pharmaceuticals

Loxo Oncology

Petra Pharma Corporation

Nura Bio

Epizyme Tech Stack

Media & News

Clementiapharma acquired Epizyme on Dec 5th '22.

Epizyme received financing of $79.8M in initial public offering on Jun 1st '13.

Epizyme went public on Jun 1st '13.

Epizyme has issues with alleged violations of the Securities Act.

Epizyme has issues with possible breach of fiduciary duties.

Epizyme hired Jerald Korn as Chief Operating Officer on Mar 15th '22.

Epizyme partners with Roche.

Epizyme's Email Address Formats

Frequently Asked Questions

Where is Epizyme's headquarters located?

What is Epizyme's phone number?

What is Epizyme's stock symbol?

What is Epizyme's official website and social media links?

What is Epizyme's SIC code NAICS code?

How many employees does Epizyme have currently?

What industry does Epizyme belong to?

What technology does Epizyme use?

What is Epizyme's email format?

When was Epizyme founded?

Epizyme

Company Overview

Media & News

Clementiapharma acquired Epizyme on Dec 5th '22.

Epizyme received financing of $79.8M in initial public offering on Jun 1st '13.

Epizyme went public on Jun 1st '13.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?